Nestmedic S.A. (WSE:NST)
Poland · Delayed Price · Currency is PLN 0.6700
-0.0140 (-2.05%)
At close: Oct 15, 2026
Nestmedic Company Description
Nestmedic S.A., together with its subsidiaries, manufactures telemedicine solutions under the Pregnabit brand.
The company offers Pregnabit Pro, a medical device for measuring fetal heart rate, uterine contraction activity, and signaling fetal movements; Pregnabit Cloud, a SaaS system for telemedical CTG devices; and Pregnabit system comprising the mobile CTG device and the medical telemonitoring center service.
It sells its products through a distribution network and resellers worldwide. The company was incorporated in 2017 and is headquartered in Warsaw, Poland.
Nestmedic S.A.
| Country | Poland |
| Founded | 2017 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Jacek Gnich |
Contact Details
Address: ul. Pasymska 20 Warsaw, 01-993 Poland | |
| Phone | 48 664 34 65 59 |
| Website | nestmedic.com |
Stock Details
| Ticker Symbol | NST |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLNSTMD00010 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Jacek Marek Gnich | President of the Management Board |
| Beata Anna Turlejska?Zdunczyk | Vice-President of the Management Board |
| Anna Skotny | Co-founder |
| Milosz Jamrozy | Director for Technology and Development |
| Dr. Ewelina Swiderek Ph.D. | Medical and Scientific Affairs Director |
| Robert Woyton | Medical Director and President of Medical Telemonitoring Center |